Results: The patient characteristics and procedures performed are similar. There is no difference in proportion of patient with hypoxemia in three groups during induction (16.7 vs 0 vs 0%, respectively) and during procedure (33.3 vs 66.7 vs 42.9%, respectively). There is no difference in proportion of patient with hypotension in three groups during induction (0 vs 0 vs 14.3%, respectively) and during procedure (33.3 vs 0 vs 0%, respectively).
The First Affiliated Hospital of Chongqing Medical University, China Background and Aims: Biopsy via the oesophagus plays an important role in the diagnosis of mediastinal lymphadenopathy and lesions, and the use of an ultrasound guided bronchoscope in the oesophagus (endobronchial ultrasound transesophageal needle aspiration, EBUS-TENA) has been proved reliable by accumulating evidence. However, EBUS relies on a high level of proficiency in sonography, and accurate identification of the anatomical structures is vital for successful harvest of samples. To circumvent the anatomical and sonographic difficulties, we have developed a simplified method of TENA.
Methods: Localization of the lesions is achieved mainly through chest CT scans instead of real-time ultrasound imaging. The distance of the lesion from the glottis or the cardia (D) was calculated by multiplying the number of planes between the glottis/cardia and the lesion (N) and the thickness of each plane (T), i.e. D = N*T. The position of the lesion relative to the oesophagus on the transverse plane is recorded by the clock position. It is of note that the clock position of the lesion when the patient lies before the pulmonologist in the procedure is different from that on the CT scan display. With these information, the lesion can be easily localized by the bronchoscope in the oesophagus, and the ultrasound probe serves to confirm the location of the lesion and distinguishes the surrounding tissues, which guarantees a safe and accurate puncture.
Results: In the 6 patients who received both procedures, the pathological diagnosis of samples harvested by the two techniques were identical (2 cases of non-small cell lung cancer, 2 adenocarcinoma, 1 , EUN-JUNG JO 1 1 Busan National University Hospital, South Korea Background and Aims: Radial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose peripheral lung cancer. However, the accuracy of molecular analysis performed on EBUS-GS specimens remains unknown in patients with non-small cell lung cancer (NSCLC).
Methods: From December 2015 to September 2017, we retrospectively studied 91 patients with peripheral NSCLC who underwent surgery after EBUS-GS. Epidermal growth factor receptor (EGFR) mutational and anaplastic lymphoma kinase (ALK) translocation status obtained from surgical specimens served as the references.
Results: Compared to the reference data, EGFR mutational testing of EBUS-GS specimens was in 97% agreement, and the κ coefficient was 0.931 (P < 0.001) (Table) . False-negative EGFR mutational data were obtained from three EBUS-GS specimens (3%) and the tumour cell numbers (estimated by pathologists) in these specimens were lower than those of other specimens. In addition, on ALK translocation testing, the results of all 91 patients were in agreement with the reference data (concordance rate of 100%, κ coefficient 1.000; P < 0.001).
Conclusion:
We found that EBUS-GS could be used for molecular diagnosis, such as EGFR mutational and ALK translocation status, in patients with peripheral NSCLC. 
